AstraZeneca, BMS Expand Development Of Diabetes Drug Dapagliflozin To Include Japan
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal is “natural progression” of two companies collaborations; dapagliflozin is currently in Phase II trials in Japan and Phase III in the U.S.